IRE1α Downregulation Enhances STING-Mediated Chemoresistance and Guides Precision Therapies in Pancreatic Cancer
RNA-seq (gene expression) · mouse · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 12 samples: 6 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE284365_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1198885 and SRA study SRP551737. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 6 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8682862 Riboseq of KPC cells without treatment,rep1 Riboseq of KPC cells wi…
- GSM8682863 Riboseq of KPC cells without treatment,rep2 Riboseq of KPC cells wi…
- GSM8682864 Riboseq of KPC cells with Cis treatment for 6h,rep1 Riboseq of KPC cells wi…
- GSM8682865 Riboseq of KPC cells with Cis treatment for 6h,rep2 Riboseq of KPC cells wi…
- GSM8682866 Riboseq of KPC cells with Cis treatment for 21h,rep1 Riboseq of KPC cells wi…
- GSM8682867 Riboseq of KPC cells with Cis treatment for 21h,rep2 Riboseq of KPC cells wi…
- GSM8682868 RNAseqseq of KPC cells without treatment,rep1 RNAseqseq of KPC cells …
- GSM8682869 RNAseqseq of KPC cells without treatment,rep2 RNAseqseq of KPC cells …
- GSM8682870 RNAseqseq of KPC cells with Cis treatment for 6h,rep1 RNAseqseq of KPC cells …
- GSM8682871 RNAseqseq of KPC cells with Cis treatment for 6h,rep2 RNAseqseq of KPC cells …
- GSM8682872 RNAseqseq of KPC cells with Cis treatment for 21h,rep1 RNAseqseq of KPC cells …
- GSM8682873 RNAseqseq of KPC cells with Cis treatment for 21h,rep2 RNAseqseq of KPC cells …
- GSE240383 Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer 27 samples shares ire1, enhances
- GSE240371 Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer [RNA-Seq] 21 samples shares ire1, enhances
- GSE263586 Vascular endothelial IRE1α promotes thrombospondin-1 mRNA decay and supports the functional adaptation of pancreatic islets upon metabolic stress 6 samples shares ire1, pancreatic
- GSE273458 Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer [scRNA-seq2] 4 samples shares ire1, enhances
- GSE240382 Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer [scRNA-seq] 2 samples shares ire1, enhances
- GSE227129 PRMT1 Promotes Epigenetic Reprogramming Associated with Acquired Chemoresistance in Pancreatic Cancer 29 samples shares chemoresistance, pancreatic
- GSE285342 DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden 7 samples shares downregulation, enhances
- GSE268555 DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden 4 samples shares downregulation, enhances
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.